Flow Cytometry Market By Component, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

The Flow Cytometry Market was valued at $6,216.42 million in 2022 and is estimated to reach $16,577.98 million by 2032, exhibiting a CAGR of 10.3% from 2023 to 2032. Flow cytometry is a powerful technique used to analyze and quantify the characteristics of individual cells or particles in a heterogeneous mixture. It operates on the principle of passing cells through a narrow, focused stream of fluid, allowing them to pass single file through a laser beam. As cells pass through the laser beam, they scatter and emit fluorescent light, which is collected by detectors. Flow cytometers can measure various parameters of each cell, including size, shape, granularity, and the presence of specific proteins or molecules tagged with fluorescent markers. This information is then processed to create a multi-dimensional profile of the cell population, providing valuable insights into cell composition, health, and function. Major factors that drive growth of the flow cytometry market include technological advancements in the flow cytometry and high adoption of flow cytometry techniques in various research and diagnostic applications.

Technological advancements in flow cytometry have emerged as a major driver in the flow cytometry market, revolutionizing the capabilities and applications of this powerful analytical technique. Flow cytometry, which allows for the rapid analysis of thousands of individual cells or particles in a heterogeneous sample, has benefited greatly from ongoing innovations in recent years. Technological advancements in fluorescence imaging and image-based analysis have revolutionized the way researchers and clinicians analyze cells and particles in fluid samples.

Fluorescence imaging, a technique that allows the visualization of cells and particles tagged with fluorescent markers, has greatly enhanced the precision and sensitivity of flow cytometry. This technology enables the simultaneous measurement of multiple parameters within individual cells, providing detailed insights into cell structure and function. For instance, in January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study was conducted in collaboration with the European Molecular Biology Laboratory. The study evaluated new BD innovation in flow cytometry that adds fluorescence imaging and image-based analysis to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Thus, the technological advancement in the flow cytometry technology is expected to drive the growth of the market.

In addition, the high adoption of flow cytometry techniques has emerged as a major driving force in the growth of the flow cytometry market, owing to its widespread utilization in diverse research and diagnostic applications. Flow cytometry, a powerful analytical tool, has gained immense popularity in the scientific community due to its ability to simultaneously analyze multiple properties of individual cells or particles at a rapid pace. In research, it has become indispensable for studying cell biology, immunology, and cancer research, allowing scientists to analyze cell populations, sort specific cell types, and assess various cellular characteristics such as size, shape, and molecular markers. Flow cytometry has also revolutionized the field of clinical diagnostics. In the realm of clinical medicine, it plays a pivotal role in the diagnosis and monitoring of various diseases, including hematological malignancies, immunodeficiency disorders, and HIV. The ability to analyze and quantify specific biomarkers on individual cells has made flow cytometry an invaluable tool for clinical laboratories. For instance, according to a 2022 report by the National Library of Medicine, flow cytometry analysis plays a critical role in the diagnosis of leukemias and other hematolymphoid malignancies. Flow cytometry can quickly identify the abnormal cell population, characterize its phenotype, give lineage classification, make the diagnosis, or narrow down the differential list. Thus, the high adoption of flow cytometry technique in various research and diagnostic applications is expected to drive the growth of the market.

However, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Moreover, preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.

The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms and replaceable components. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others.

On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. As per application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others.

The diagnostic applications segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global flow cytometry market are Agilent Technologies, Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow cytometry market analysis from 2022 to 2032 to identify the prevailing flow cytometry market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the flow cytometry market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global flow cytometry market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Average Selling Price Analysis / Price Point Analysis
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Component

Instruments
- Type
- Platform

Type

Replaceable component

Type

Reagents and consumables
- Type
- Antibodies
- Dyes
- Beads
- Others
Software
Services

By Technology

Cell based flow cytometry
Bead based flow cytometry

By Application

Academic and clinical applications
- Type
- Cell Cycle Analysis and Cell Proliferation
- Apoptosis
- Cell Sorting
- Transfect Ion and Cell Viability
- Others
Diagnostic applications
- Type
- Organ Transplantation
- Hematological Malignancies
- HIV
- Solid Tumors and Cancer
- Others

By End User

Hospitals
Medical schools and clinical testing labs
Commercial organizations
Academic institutions
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH.
Sartorius AG
Agilent Technologies, Inc.
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Sysmex Corporation
Danaher Corporation
Cytek Biosciences
BioMerieux SA

Product Code: A00023

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Technological advancements
  - 3.4.1.2. High adoption of flow cytometry technique in disease diagnosis
  - 3.4.1.3. Surge in adoption of flow cytometry technique in drug discovery and development.
- 3.4.2. Restraints
  - 3.4.2.1. High cost of instrument
- 3.4.3. Opportunities
  - 3.4.3.1. Integration of AI in flow cytometry

CHAPTER 4: FLOW CYTOMETRY MARKET, BY COMPONENT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Instruments
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Instruments Flow Cytometry Market by Type
  - 4.2.4.1. Platform Flow Cytometry Market by Type
  - 4.2.4.2. Replaceable component Flow Cytometry Market by Type
4.3. Reagents and consumables
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Reagents and consumables Flow Cytometry Market by Type
4.4. Software
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Services
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country

CHAPTER 5: FLOW CYTOMETRY MARKET, BY TECHNOLOGY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Cell based flow cytometry
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Bead based flow cytometry
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: FLOW CYTOMETRY MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Academic and clinical applications
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.2.4. Academic and clinical applications Flow Cytometry Market by Type
6.3. Diagnostic applications
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.3.4. Diagnostic applications Flow Cytometry Market by Type

CHAPTER 7: FLOW CYTOMETRY MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Hospitals
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Medical schools and clinical testing labs
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Commercial organizations
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
7.5. Academic institutions
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
7.6. Others
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country

CHAPTER 8: FLOW CYTOMETRY MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Component
- 8.2.3. Market size and forecast, by Technology
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by Component
  - 8.2.6.1.2. Market size and forecast, by Technology
  - 8.2.6.1.3. Market size and forecast, by Application
  - 8.2.6.1.4. Market size and forecast, by End User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by Component
  - 8.2.6.2.2. Market size and forecast, by Technology
  - 8.2.6.2.3. Market size and forecast, by Application
  - 8.2.6.2.4. Market size and forecast, by End User
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by Component
  - 8.2.6.3.2. Market size and forecast, by Technology
  - 8.2.6.3.3. Market size and forecast, by Application
  - 8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Component
- 8.3.3. Market size and forecast, by Technology
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by Component
  - 8.3.6.1.2. Market size and forecast, by Technology
  - 8.3.6.1.3. Market size and forecast, by Application
  - 8.3.6.1.4. Market size and forecast, by End User
  - 8.3.6.2. France
  - 8.3.6.2.1. Market size and forecast, by Component
  - 8.3.6.2.2. Market size and forecast, by Technology
  - 8.3.6.2.3. Market size and forecast, by Application
  - 8.3.6.2.4. Market size and forecast, by End User
  - 8.3.6.3. UK
  - 8.3.6.3.1. Market size and forecast, by Component
  - 8.3.6.3.2. Market size and forecast, by Technology
  - 8.3.6.3.3. Market size and forecast, by Application
  - 8.3.6.3.4. Market size and forecast, by End User
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Market size and forecast, by Component
  - 8.3.6.4.2. Market size and forecast, by Technology
  - 8.3.6.4.3. Market size and forecast, by Application
  - 8.3.6.4.4. Market size and forecast, by End User
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Market size and forecast, by Component
  - 8.3.6.5.2. Market size and forecast, by Technology
  - 8.3.6.5.3. Market size and forecast, by Application
  - 8.3.6.5.4. Market size and forecast, by End User
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by Component
  - 8.3.6.6.2. Market size and forecast, by Technology
  - 8.3.6.6.3. Market size and forecast, by Application
  - 8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Component
- 8.4.3. Market size and forecast, by Technology
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Market size and forecast, by Component
  - 8.4.6.1.2. Market size and forecast, by Technology
  - 8.4.6.1.3. Market size and forecast, by Application
  - 8.4.6.1.4. Market size and forecast, by End User
  - 8.4.6.2. China
  - 8.4.6.2.1. Market size and forecast, by Component
  - 8.4.6.2.2. Market size and forecast, by Technology
  - 8.4.6.2.3. Market size and forecast, by Application
  - 8.4.6.2.4. Market size and forecast, by End User
  - 8.4.6.3. Australia
  - 8.4.6.3.1. Market size and forecast, by Component
  - 8.4.6.3.2. Market size and forecast, by Technology
  - 8.4.6.3.3. Market size and forecast, by Application
  - 8.4.6.3.4. Market size and forecast, by End User
  - 8.4.6.4. India
  - 8.4.6.4.1. Market size and forecast, by Component
  - 8.4.6.4.2. Market size and forecast, by Technology
  - 8.4.6.4.3. Market size and forecast, by Application
  - 8.4.6.4.4. Market size and forecast, by End User
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Market size and forecast, by Component
  - 8.4.6.5.2. Market size and forecast, by Technology
  - 8.4.6.5.3. Market size and forecast, by Application
  - 8.4.6.5.4. Market size and forecast, by End User
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by Component
  - 8.4.6.6.2. Market size and forecast, by Technology
  - 8.4.6.6.3. Market size and forecast, by Application
  - 8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Component
- 8.5.3. Market size and forecast, by Technology
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by Component
  - 8.5.6.1.2. Market size and forecast, by Technology
  - 8.5.6.1.3. Market size and forecast, by Application
  - 8.5.6.1.4. Market size and forecast, by End User
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Market size and forecast, by Component
  - 8.5.6.2.2. Market size and forecast, by Technology
  - 8.5.6.2.3. Market size and forecast, by Application
  - 8.5.6.2.4. Market size and forecast, by End User
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Market size and forecast, by Component
  - 8.5.6.3.2. Market size and forecast, by Technology
  - 8.5.6.3.3. Market size and forecast, by Application
  - 8.5.6.3.4. Market size and forecast, by End User
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Market size and forecast, by Component
  - 8.5.6.4.2. Market size and forecast, by Technology
  - 8.5.6.4.3. Market size and forecast, by Application
  - 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Agilent Technologies, Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. Becton, Dickinson and Company
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
10.3. BioMerieux SA
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
10.4. Bio-Rad Laboratories, Inc.
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
10.5. Danaher Corporation
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
10.6. Miltenyi Biotec GmbH.
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
10.7. Sartorius AG
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
10.8. Sysmex Corporation
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
10.9. Thermo Fisher Scientific Inc.
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments
10.10. Cytek Biosciences
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio